Three insights:
1. Tactoset is a surgically delivered regenerative therapy for the treatment of bone voids and other bone defects caused by trauma or age-related degeneration.
2. The therapy fuses calcium phosphate with Anika’s hyaluronic acid, which improves flow and tactile feel during administration to enhance the procedural efficacy.
3. Tactoset is designed for ease of use and aims to decrease OR time in procedures to treat bone defects.
More articles on biologics:
Dr. Tony Mork: Reimbursement, lack of training shackles progress of endoscopic spine surgery
Neurosurgeon Dr. Griff Harsh joins ownership group of MLS franchise
DePuy Synthes recalls devices used in spine fixation system: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
